Structural, Clinical and Economical Perspectives of Covid-19

This book provides a detailed overview of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19, which emerged in Wuhan, China in late 2019. It explores the virus's origins, transmission, and its potential zoonotic nature, with insights into its structure and genetic makeup. The book also examines the urgent global response to identify antiviral drugs and potential treatments, with a focus on therapeutic targets such as the spike protein and viral RNA polymerase. Aimed at researchers, healthcare professionals, and students, this resource offers essential information on the biology, spread, and therapeutic strategies for combating SARS-CoV-2.

SARS-CoV-2, the novel coronavirus responsible for the COVID-19 pandemic, emerged in Wuhan, China in late 2019 and rapidly spread worldwide. This book explores the virus's origins, structural components, and transmission mechanisms, with a focus on its interaction with host cells via the spike protein and ACE-2 receptor. Given the absence of a specific treatment, the book emphasizes the urgent need for antiviral drug discovery and highlights potential therapeutic targets, such as viral entry mechanisms and RNA polymerase activity. The work serves as a critical resource for understanding SARS-CoV-2 biology and strategies to combat the ongoing pandemic.

---